Language selection

Government of Canada

Search

2010-02-16 - Male - 11 Years old

338062

Adverse reaction report number 338062
Latest AER version number 0
Market authorization holder AER number N/A
Initial received date 2010-02-16
Latest received date 2010-02-16
Age 11 Years
Gender Male
Weight N/A
Type of report Spontaneous
Reporter type Pharmacist
Source of report Community
Report outcome Unknown
Serious report? No

Product information

Product description Dosage form Health product role Route of administration Dose Frequency Therapy duration Indication(s)
ADDERALL XRCAPSULE, EXTENDED RELEASESuspectUnknown
IBUPROFENTABLETSuspectUnknown2 Dosage forms
SERTRALINESuspectOral50 Milligram1 every 1 Day(s) Abnormal behaviour
SERTRALINESuspectOral50 Milligram1 every 1 Day(s) Attention deficit/hyperactivity disorder
SERTRALINECAPSULESuspectOral25 Milligram1 every 1 Day(s) Abnormal behaviour
SERTRALINECAPSULESuspectOral25 Milligram1 every 1 Day(s) Attention deficit/hyperactivity disorder

Adverse reaction term information

MedDRA version: v.21.1
Adverse reaction terms Reaction duration
Dizziness
Epistaxis
Haemorrhage
Psychomotor hyperactivity
Date modified: